TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15345 · Dec 19

#typescript#agent#agentic#agentic_ai#agents#agents_sdk#ai#ai_agents#aiagentframework#genai#genai_chatbot#llm#llms#multi_agent#multi_agent_systems#multi_agents#multi_agents_collaboration Agent Development Kit (ADK) for TypeScript is an open-source toolkit to build, test, and deploy advanced AI agents with full control in code. Key features include rich tools like Google Search, custom functions, and multi-agent hierarchies for scalable apps, plus a dev UI for easy debugging. Install via npm install @google/adk. You benefit by creating flexible, versioned AI agents that integrate tightly with Google Cloud, run anywhere from laptop to cloud, and speed up development like regular software. https://github.com/google/adk-js

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment